MCPARTLAND MARK A. 4

4 · VistaGen Therapeutics, Inc. · Filed Aug 31, 2018

Form 4

Period: 2018-08-29

VP Corporate Development

Transactions

Award
Stock Option (Right to Buy)
2018-08-29+125,000→ 125,000 total
Exercise: $1.50Exp: 2026-09-29→ Common Stock (125,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−40,000→ 0 total
Exercise: $3.80Exp: 2026-11-09→ Common Stock (40,000 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+100,000→ 250,000 total
Exercise: $1.50Exp: 2027-04-26→ Common Stock (100,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−125,000→ 0 total
Exercise: $4.27Exp: 2026-09-29→ Common Stock (125,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−100,000→ 0 total
Exercise: $1.96Exp: 2027-04-26→ Common Stock (100,000 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+40,000→ 40,000 total
Exercise: $1.50Exp: 2026-11-09→ Common Stock (40,000 underlying)

Footnotes (6)

[F1]The reporting person agreed to cancellation of an option granted to him on 9/29/2016 in exchange for a new option having a lower exercise price.
[F2]The option vests monthly over a period of four years commencing 9/29/2016.
[F3]The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price.
[F4]The option vests monthly over a period of three years commencing 11/9/2016.
[F5]The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price.
[F6]The option vests monthly over a period of three years commencing 4/26/2017.

Documents

1 file